Flawed FLAURA Comparisons and Nonrandom Biomarker Missingness in U.S. Osimertinib Cohort Study

Shenglong Li1, Cuicui Wang2

  • 1Second Ward of Bone and Soft Tissue Tumor Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, People's Republic of China; The Liaoning Provincial Key Laboratory of Interdisciplinary Research on Gastrointestinal Tumor Combining Medicine with Engineering, Shenyang, People's Republic of China; Institute of Cancer Medicine, Faculty of Medicine, Dalian University of Technology, Dalian, People's Republic of China.

Summary

No abstract available in PubMed .